These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 396111)

  • 1. Placebo-controlled, double-blind clinical trial of alprenolol in African hypertensive patients.
    Salako LA; Falase AO; Aderounmu AF
    Curr Med Res Opin; 1979; 6(5):358-63. PubMed ID: 396111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
    Tuomilehto J; Nissinen A
    Eur J Clin Pharmacol; 1979; 16(6):369-74. PubMed ID: 393518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
    Pape J
    Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
    [No Abstract]   [Full Text] [Related]  

  • 5. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.
    Collste P; Haglund K; Frisk-Holmberg M; Orme ML; Rawlins MD; Ostman J
    Eur J Clin Pharmacol; 1976 Jun; 10(2):89-95. PubMed ID: 964292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between alprenolol and propranolol as antihypertensive agents. A double-blind cross-over study.
    Bengtsson C
    Acta Med Scand; 1972 Nov; 192(5):415-8. PubMed ID: 4563325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind (author's transl)].
    Cartier F; Merot ML
    Sem Hop; 1978 Sep 18-25; 54(25-28):855-7. PubMed ID: 214866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
    Tuomilehto J
    Acta Med Scand Suppl; 1979; 625():74-80. PubMed ID: 373397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effect of alprenolol as antihypertensive agent.
    Bengtsson C
    Acta Med Scand Suppl; 1974; 554():9-14. PubMed ID: 4593676
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of adrenergic-blocking drugs.
    Louis WJ; Rand MJ; McNeil JJ; Drummer O; Jarrott B
    Cardiology; 1979; 64 Suppl 1():96-104. PubMed ID: 42490
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension.
    Tuomilehto J; Puska P; Mustaniemi H
    Acta Med Scand Suppl; 1974; 554():47-54. PubMed ID: 4593673
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of alprenolol in elderly patients with raised blood pressure.
    Eisalo A; Heino A; Munter J
    Acta Med Scand Suppl; 1974; 554():23-31. PubMed ID: 4593670
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.
    Seideman P; Borg KO; Haglund K; Von Bahr C
    Br J Clin Pharmacol; 1987 Mar; 23(3):267-71. PubMed ID: 3567041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.
    Castenfors J; Johnsson H; Orö L
    Acta Med Scand; 1973 Mar; 193(3):189-95. PubMed ID: 4571479
    [No Abstract]   [Full Text] [Related]  

  • 18. The long-term effect of alprenolol on plasma apolipoproteins A-I and B.
    Gerdes LU; Jürgensen HJ; Groot PH; Faergeman O
    Acta Med Scand; 1988; 223(5):419-22. PubMed ID: 3132028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
    Vedin JA; Wilhelmsson CE; Werkö L
    Br Heart J; 1973 Dec; 35(12):1285-92. PubMed ID: 4586374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
    Pape J
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1139-42. PubMed ID: 4584539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.